Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta blockers and ACEI/ARB in MINOCA
NCT03686696Phase 4Terminated
- Sponsor
- Uppsala University
- Start
- Dec 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial of carvedilol in myocardial infarction with nonobstructive coronary arteries (MINOCA), sponsored by Uppsala University. Started Dec 2018; status: terminated.
02
Drugs
carvedilol
03
Conditions
myocardial infarction with nonobstructive coronary arteries (MINOCA)
Beyond the preview
Go deeper on NCT03686696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686696.